COVID-19 pathogenesis is associated with an exaggerated immune response. However, the specific cellular mediators and inflammatory components driving diverse clinical disease outcomes remain poorly understood. In this webinar sponsored by Advanced Cell Diagnostics (ACD), Madhvi Menon will describe the longitudinal immune profiling of hospitalized patients during the peak of the COVID-19 pandemic in the UK, and the key immune signatures that associated with disease severity. Additionally, Jyoti Phatak-Sheldon will describe what researchers can learn about COVID-19 using ACD’s RNAscope in situ hybridization technology with RNA probes specific for SARS-CoV-2.
- Immune profiling of COVID-19 patients in the UK
- Immune signatures associated with severe COVID-19
- Changes in immune signatures after recovery
- RNAscope in situ hybridization technology specific for SARS-CoV-2